FINWIRES · TerminalLIVE
FINWIRES

Update: Mizuho Securities Keeps Terns Pharmaceuticals to Neutral, Price Target to $53

作者

-- (Updated to keep rating and price target unchanged).

Terns Pharmaceuticals (TERN) has an average rating of hold and mean price target of $53, according to analysts polled by FactSet.

(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

相关文章